Fulgent Genetics Inc (FLGT)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 104,456 92,214 98,465 143,169 366,901 543,451 681,758 734,240 777,051 830,720 721,773 613,563 331,905 93,452 24,459 19,715 18,421 16,572 13,123 11,175
Revenue (ttm) US$ in thousands 289,213 286,412 307,380 364,868 618,968 802,935 925,148 953,423 992,584 1,035,891 909,739 773,388 421,712 135,121 43,752 34,911 32,528 29,814 25,092 22,068
Gross profit margin 36.12% 32.20% 32.03% 39.24% 59.28% 67.68% 73.69% 77.01% 78.29% 80.19% 79.34% 79.33% 78.70% 69.16% 55.90% 56.47% 56.63% 55.58% 52.30% 50.64%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $104,456K ÷ $289,213K
= 36.12%

The gross profit margin of Fulgent Genetics Inc has displayed significant fluctuations over the past eight quarters. In Q4 2023, the gross profit margin stood at 36.12%, representing a slight increase from the previous quarter. However, this figure is notably lower compared to the levels observed in Q4 2022, where the gross profit margin was substantially higher at 59.28%.

The trend in the gross profit margin indicates a decreasing pattern over the analyzed period, suggesting potential challenges in managing production costs or pricing strategies. It is important for investors and stakeholders to closely monitor future financial reports to assess the company's ability to improve its gross profit margin and sustain profitability.


Peer comparison

Dec 31, 2023